FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012604152> ?p ?o ?g. }

• W2012604152 endingPage "530" @default.
• W2012604152 startingPage "522" @default.
• W2012604152 abstract "The possible role of hyperprolactinemia in the sexual and thyroid abnormalities of patients with end-stage renal failure was studied in 56 patients undergoing long-term hemodialysis. Seventy-three per cent of the women and 25 per cent of the men receiving no prolactin (PRL)-enhancing drugs had elevated PRL levels (25 to 200 ng/ml, normal <20 ng/ml), and all those patients who were receiving α-methyldopa treatment (13 patients) had even higher PRL levels (30 to 1,107 ng/ml). The response of PRL to the administration of thyrotropin-releasing hormone (TRH) was blunted and prolonged, suggesting that hyperprolactinemia was in part due to prolonged plasma half-life of the hormones; this was confirmed by the insufficient PRL lowering effect of a single dose of bromocriptine in a short-term test, whereas a longer trial of six weeks demonstrated the PRL-suppressive effect of the drug. Amenorrhea or oligomenorrhea was a constant feature in women, four of whom also showed galactorrhea; during bromocriptine treatment, recurrence of menses was observed in some of the hyperprolactinemic amenorrheic women. Men with impotence had higher PRL levels than men with normal potency. Lack of appropriate elevation of luteinizing hormone (LH) levels despite low estradiol or testosterone levels was observed in approximately one third of the hyperprolactinemic subjects of both sexes, but also in a similar proportion of normoprolactinemic ones. However, treatment with bromocriptine resulted in an increase in basal LH in 13 of 16 patients with hyperprolactinemia. These data demonstrate that PRL measured in patients with advanced renal failure is biologically active and that hyperprolactinemia is one of the major factors in the hypogonadism of these patients. In addition, integrated circulating LH after the injection of exogenous luteinizing hormone-releasing hormone (LHRH) was normal, despite prolonged plasma half-life, suggesting that pituitary response was in fact impaired. Unrelated to PRL levels, 47 per cent of the patients had slightly elevated thyroid-stimulating hormone (TSH) levels, with normal total and free thyroxine (T4). Although triiodothyronine (T3) tended to cluster in the low-normal area, reverse-T3 levels were not consistent with preferential deiodination of T4 to reverse-T3. Elevation of the basal TSH levels was, at least in part, due to prolonged plasma half-life of the hormone. These biochemical changes were not related to clinically detectable dysfunction of the thyroid." @default.
• W2012604152 created "2016-06-24" @default.
• W2012604152 creator A5019411057 @default.
• W2012604152 creator A5025503821 @default.
• W2012604152 creator A5033201382 @default.
• W2012604152 creator A5036632764 @default.
• W2012604152 date "1980-04-01" @default.
• W2012604152 modified "2023-10-17" @default.
• W2012604152 title "Endocrine abnormalities in patients undergoing long-term hemodialysis" @default.
• W2012604152 cites W1530509338 @default.
• W2012604152 cites W1915463020 @default.
• W2012604152 cites W1975261266 @default.
• W2012604152 cites W1976590338 @default.
• W2012604152 cites W1977809437 @default.
• W2012604152 cites W1992569535 @default.
• W2012604152 cites W1996390002 @default.
• W2012604152 cites W1997930427 @default.
• W2012604152 cites W2006812071 @default.
• W2012604152 cites W2009600326 @default.
• W2012604152 cites W2012149379 @default.
• W2012604152 cites W2030777262 @default.
• W2012604152 cites W2033910283 @default.
• W2012604152 cites W2041386133 @default.
• W2012604152 cites W2048970076 @default.
• W2012604152 cites W2049597076 @default.
• W2012604152 cites W2049924703 @default.
• W2012604152 cites W2057920073 @default.
• W2012604152 cites W2062390535 @default.
• W2012604152 cites W2065379801 @default.
• W2012604152 cites W2072689813 @default.
• W2012604152 cites W2073355765 @default.
• W2012604152 cites W2074544869 @default.
• W2012604152 cites W2114422277 @default.
• W2012604152 cites W2120681566 @default.
• W2012604152 cites W2144643137 @default.
• W2012604152 cites W2325148966 @default.
• W2012604152 cites W2338099022 @default.
• W2012604152 cites W2341173760 @default.
• W2012604152 cites W2412307587 @default.
• W2012604152 cites W3023534667 @default.
• W2012604152 doi "https://doi.org/10.1016/0002-9343(80)90296-x" @default.
• W2012604152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6768290" @default.
• W2012604152 hasPublicationYear "1980" @default.
• W2012604152 type Work @default.
• W2012604152 sameAs 2012604152 @default.
• W2012604152 citedByCount "161" @default.
• W2012604152 countsByYear W20126041522012 @default.
• W2012604152 countsByYear W20126041522013 @default.
• W2012604152 countsByYear W20126041522014 @default.
• W2012604152 countsByYear W20126041522015 @default.
• W2012604152 countsByYear W20126041522016 @default.
• W2012604152 countsByYear W20126041522017 @default.
• W2012604152 countsByYear W20126041522018 @default.
• W2012604152 countsByYear W20126041522019 @default.
• W2012604152 countsByYear W20126041522020 @default.
• W2012604152 countsByYear W20126041522021 @default.
• W2012604152 countsByYear W20126041522022 @default.
• W2012604152 countsByYear W20126041522023 @default.
• W2012604152 crossrefType "journal-article" @default.
• W2012604152 hasAuthorship W2012604152A5019411057 @default.
• W2012604152 hasAuthorship W2012604152A5025503821 @default.
• W2012604152 hasAuthorship W2012604152A5033201382 @default.
• W2012604152 hasAuthorship W2012604152A5036632764 @default.
• W2012604152 hasConcept C126322002 @default.
• W2012604152 hasConcept C134018914 @default.
• W2012604152 hasConcept C2776216936 @default.
• W2012604152 hasConcept C2776856834 @default.
• W2012604152 hasConcept C2777863693 @default.
• W2012604152 hasConcept C2778024521 @default.
• W2012604152 hasConcept C2778058571 @default.
• W2012604152 hasConcept C2778063415 @default.
• W2012604152 hasConcept C2778575703 @default.
• W2012604152 hasConcept C2779064019 @default.
• W2012604152 hasConcept C2779234561 @default.
• W2012604152 hasConcept C2779279991 @default.
• W2012604152 hasConcept C2779306644 @default.
• W2012604152 hasConcept C4134927 @default.
• W2012604152 hasConcept C46699223 @default.
• W2012604152 hasConcept C54355233 @default.
• W2012604152 hasConcept C71315377 @default.
• W2012604152 hasConcept C71924100 @default.
• W2012604152 hasConcept C86803240 @default.
• W2012604152 hasConceptScore W2012604152C126322002 @default.
• W2012604152 hasConceptScore W2012604152C134018914 @default.
• W2012604152 hasConceptScore W2012604152C2776216936 @default.
• W2012604152 hasConceptScore W2012604152C2776856834 @default.
• W2012604152 hasConceptScore W2012604152C2777863693 @default.
• W2012604152 hasConceptScore W2012604152C2778024521 @default.
• W2012604152 hasConceptScore W2012604152C2778058571 @default.
• W2012604152 hasConceptScore W2012604152C2778063415 @default.
• W2012604152 hasConceptScore W2012604152C2778575703 @default.
• W2012604152 hasConceptScore W2012604152C2779064019 @default.
• W2012604152 hasConceptScore W2012604152C2779234561 @default.
• W2012604152 hasConceptScore W2012604152C2779279991 @default.
• W2012604152 hasConceptScore W2012604152C2779306644 @default.
• W2012604152 hasConceptScore W2012604152C4134927 @default.
• W2012604152 hasConceptScore W2012604152C46699223 @default.
• W2012604152 hasConceptScore W2012604152C54355233 @default.

• next